Archives of Women's Mental Health

, Volume 16, Issue 5, pp 343–351

Biologically based treatment approaches to the patient with resistant perinatal depression

Review Article

Abstract

This study aims to summarize the current state of knowledge regarding approaches to treatment-resistant depression in pregnancy and the postpartum period and to develop algorithms for ante- and postnatal management in cases of refractory major depression. PubMed, Scopus, Google Scholar, and the Cochrane Library databases were searched without temporal restriction. Search terms included pregnancy and depression, perinatal depression, postnatal depression, treatment resistance and depression, antipsychotics and pregnancy, antidepressants and pregnancy, and mood stabilizers and pregnancy. Abstracts were reviewed for relevance, and further articles were obtained from bibliographic citations. There is a significant subpopulation of patients in pregnancy and postpartum whose depressive symptoms do not respond to first-line treatments. No research studies have focused specifically on this population. Data extracted from studies on women with depressive symptoms in pregnancy suggest that in the absence of evidence on which to base clinical decisions, many are receiving combinations of psychotherapeutic medications that have not been specifically studied for use in pregnancy. Antidepressant use in pregnancy is well studied, but studies specifically addressing the case of the patient who does not respond to first-line treatments are absent. Research in this area is urgently needed. The authors review a number of possible therapeutic approaches to treatment-resistant depression in pregnancy and the postpartum period.

Keywords

Treatment-resistant depression Pregnancy Antenatal depression Postpartum depression Antidepressants 

References

  1. Ahokas A, Kaukoranta J, Wahlbeck K, Aito M (2001) Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17beta-estradiol: a preliminary study. J Clin Psychiatry 62(5):332–336PubMedCrossRefGoogle Scholar
  2. Anderson EL, Reti IM (2009) ECT in pregnancy: a review of the literature from 1941 to 2007. Psychosomatic Medicine 71(2):235–242PubMedCrossRefGoogle Scholar
  3. Appleby L, Warner R, Whitton A, Faragher B (1997) A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression. BMJ 314(7085):932–936PubMedCrossRefGoogle Scholar
  4. Balki M, Castro C, Ananthanarayan C (2006) Status epilepticus after electroconvulsive therapy in a pregnant patient. Int J Obstet Anesth 15(4):325–328PubMedCrossRefGoogle Scholar
  5. Berlim MT, Turecki G (2007a) Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods. Can J Psychiatr Revue Canadienne De Psychiatrie 52(1):46–54Google Scholar
  6. Berlim MT, Turecki G (2007b) What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials. Eur Neuropsychopharmacol 17(11):696–707PubMedCrossRefGoogle Scholar
  7. Bloch M, Daly RC, Rubinow DR (2003) Endocrine factors in the etiology of postpartum depression. Comprehensive Psychiatry 44(3):234–246PubMedCrossRefGoogle Scholar
  8. Bobo WV, Shelton RC (2009) Fluoxetine and olanzapine combination therapy in treatment-resistant major depression: review of efficacy and safety data. Expert Opin Pharmacother 10(13):2145–2159PubMedCrossRefGoogle Scholar
  9. Brand SR, Brennan PA (2009) Impact of antenatal and postpartum maternal mental illness: how are the children? Clin Obstet Gynecol 52(3):441–455PubMedCrossRefGoogle Scholar
  10. Brandon AR, Freeman MP (2011) When she says “no” to medication: psychotherapy for antepartum depression. Current Psychiatry Reports 13(6):459–466PubMedCrossRefGoogle Scholar
  11. Byatt N, Deligiannidis KM, Freeman MP (2013) Antidepressant use in pregnancy: a critical review focused on risks and controversies. Acta Psychiatr Scand 127(2):94–114PubMedCrossRefGoogle Scholar
  12. Chabrol H, Teissedre F, Saint-Jean M, Teisseyre N, Roge B, Mullet E (2002) Prevention and treatment of post-partum depression: a controlled randomized study on women at risk. Psychol Med 32(6):1039–1047PubMedCrossRefGoogle Scholar
  13. Chatzicharalampous C, Rizos D, Pliatsika P, Leonardou A, Hasiakos D, Zervas I et al (2011) Reproductive hormones and postpartum mood disturbances in Greek women. Gynecol Endocrinol 27(8):543–550PubMedCrossRefGoogle Scholar
  14. Cohen LS, Viguera AC, Bouffard SM, Nonacs RM, Morabito C, Collins MH et al (2001) Venlafaxine in the treatment of postpartum depression. J Clin Psychiatr 62(8):592–596CrossRefGoogle Scholar
  15. Cohen LS, Altshuler LL, Harlow BL, Nonacs R, Newport DJ, Viguera AC et al (2006) Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 295(5):499–507PubMedCrossRefGoogle Scholar
  16. Cooper PJ, Murray L, Wilson A, Romaniuk H (2003) Controlled trial of the short- and long-term effect of psychological treatment of post-partum depression. I. Impact on maternal mood. Br J Psychiatr 182:412–419CrossRefGoogle Scholar
  17. Coppola D, Russo LJ, Kwarta RF Jr, Varughese R, Schmider J (2007) Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes. Drug Saf 30(3):247–264PubMedCrossRefGoogle Scholar
  18. Coverdale JH, McCullough LB, Chervenak FA (2008) The ethics of randomized placebo-controlled trials of antidepressants with pregnant women: a systematic review. Obstet Gynecol 112(6):1361–1368PubMedCrossRefGoogle Scholar
  19. Cuijpers P, Brannmark JG, van Straten A (2008) Psychological treatment of postpartum depression: a meta-analysis. J Clin Psychol 64(1):103–118PubMedCrossRefGoogle Scholar
  20. Danielsson I, Lister L (2009) A pilot study of the teratogenicity of vagus nerve stimulation in a rabbit model. Brain Stimulation 2(1):41–49PubMedCrossRefGoogle Scholar
  21. Davalos DB, Yadon CA, Tregellas HC (2012) Untreated prenatal maternal depression and the potential risks to offspring: a review. Archives of Women’s Mental Health 15(1):1–14PubMedCrossRefGoogle Scholar
  22. Deligiannidis KM (2010) Therapeutic drug monitoring in pregnant and postpartum women: recommendations for SSRIs, lamotrigine, and lithium. J Clin Psychiatr 71(5):649–650CrossRefGoogle Scholar
  23. Dennis CL, Hodnett E (2007) Psychosocial and psychological interventions for treating postpartum depression. Cochrane Database of Systematic Reviews (4):CD006116Google Scholar
  24. Dennis CL, Ross LE, Grigoriadis S (2007) Psychosocial and psychological interventions for treating antenatal depression. Cochrane Database of Systematic Reviews (3):CD006309Google Scholar
  25. Dietz PM, Williams SB, Callaghan WM, Bachman DJ, Whitlock EP, Hornbrook MC (2007) Clinically identified maternal depression before, during, and after pregnancies ending in live births. Am J Psychiatry 164(10):1515–1520PubMedCrossRefGoogle Scholar
  26. Dimidjian S, Goodman S (2009) Nonpharmacologic intervention and prevention strategies for depression during pregnancy and the postpartum. Clin Obstet Gynecol 52(3):498–515PubMedCrossRefGoogle Scholar
  27. Echevarria Moreno M, Martin Munoz J, Sanchez Valderrabanos J, Vazquez Gutierrez T (1998) Electroconvulsive therapy in the first trimester of pregnancy. The Journal of ECT 14(4):251–254PubMedGoogle Scholar
  28. Epstein RA, Bobo WV, Shelton RC, Arbogast PG, Morrow JA, Wang W et al (2012) Increasing use of atypical antipsychotics and anticonvulsants during pregnancy. Pharmacoepidemiol Drug Saf. doi:10.1002/pds.3366 PubMedGoogle Scholar
  29. Fahy BG (2010) Intraoperative and perioperative complications with a vagus nerve stimulation device. J Clin Anesth 22(3):213–222PubMedCrossRefGoogle Scholar
  30. Field T (2011) Prenatal depression effects on early development: a review. Infant Behav Dev 34(1):1–14PubMedCrossRefGoogle Scholar
  31. Fink M (2011) Transcranial magnetic stimulation is not a replacement for electroconvulsive therapy in depressive mood disorders. The Journal of ECT 27(1):3–4PubMedCrossRefGoogle Scholar
  32. Forssman H (1955) Follow-up study of sixteen children whose mothers were given electric convulsive therapy during gestation. Acta Psychiatrica Et Neurologica Scandinavica 30(3):437–441PubMedCrossRefGoogle Scholar
  33. Gahr M, Blacha C, Connemann BJ, Freudenmann RW, Schonfeldt-Lecuona C (2011) Successful treatment of major depression with electroconvulsive therapy in a pregnant patient with previous non-response to prefrontal rTMS. Pharmacopsychiatry 45(2):79–80PubMedGoogle Scholar
  34. Galbally M, Roberts M, Buist A (2010) Mood stabilizers in pregnancy: a systematic review. Aust New Zeal J Psychiatr 44(11):967–977Google Scholar
  35. Garber J, Ciesla JA, McCauley E, Diamond G, Schloredt KA (2011) Remission of depression in parents: links to healthy functioning in their children. Child Development 82(1):226–243PubMedCrossRefGoogle Scholar
  36. Garcia KS, Flynn P, Pierce KJ, Caudle M (2010) Repetitive transcranial magnetic stimulation treats postpartum depression. Brain Stimulation 3(1):36–41PubMedCrossRefGoogle Scholar
  37. Gentile S (2010) Antipsychotic therapy during early and late pregnancy. A systematic review. Schizophr Bull 36(3):518–544PubMedCrossRefGoogle Scholar
  38. George MS, Rush AJ, Marangell LB, Sackeim HA, Brannan SK, Davis SM et al (2005) A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiatry 58(5):364–373PubMedCrossRefGoogle Scholar
  39. Gilot B, Gonzalez D, Bournazeau JA, Barriere A, Van Lieferinghen P (1999) Case report: electroconvulsive therapy during pregnancy (electroconvulsivotherapie au troisieme trimestre de grossesse: a propos d’un cas). L’Encephale 25(6):590–594PubMedGoogle Scholar
  40. Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JW (1996) Transdermal oestrogen for treatment of severe postnatal depression. Lancet 347(9006):930–933PubMedCrossRefGoogle Scholar
  41. Hendrick V, Altshuler L, Strouse T, Grosser S (2000) Postpartum and nonpostpartum depression: differences in presentation and response to pharmacologic treatment. Depress Anxiety 11(2):66–72PubMedCrossRefGoogle Scholar
  42. Honey KL, Bennett P, Morgan M (2002) A brief psycho-educational group intervention for postnatal depression. Br J Clin Psychol 41(Pt 4):405–409PubMedCrossRefGoogle Scholar
  43. Hostetter A, Stowe ZN, Strader JR Jr, McLaughlin E, Llewellyn A (2000) Dose of selective serotonin uptake inhibitors across pregnancy: clinical implications. Depression and Anxiety 11(2):51–57PubMedCrossRefGoogle Scholar
  44. Houser MV, Hennessy MD, Howard BC (2010) Vagal nerve stimulator use during pregnancy for treatment of refractory seizure disorder. Obstet Gynecol 115(2 Pt 2):417–419PubMedCrossRefGoogle Scholar
  45. Husain MM, Stegman D, Trevino K (2005) Pregnancy and delivery while receiving vagus nerve stimulation for the treatment of major depression: a case report. Annals of General Psychiatry 4:16PubMedCrossRefGoogle Scholar
  46. Impastato DJ, Gabriel AR, Lardaro HH (1964) Electric and insulin shock therapy during pregnancy. Diseases of the Nervous System 25:542–546PubMedGoogle Scholar
  47. Johnson KC, Laprairie JL, Brennan PA, Stowe ZN, Newport DJ (2012) Prenatal antipsychotic exposure and neuromotor performance during infancy. Arch Gen Psychiatry 69(8):787–94PubMedCrossRefGoogle Scholar
  48. Kim DR, Epperson N, Pare E, Gonzalez JM, Parry S, Thase ME et al (2011) An open label pilot study of transcranial magnetic stimulation for pregnant women with major depressive disorder. Journal of Women’s Health 20(2):255–261PubMedCrossRefGoogle Scholar
  49. Klier CM, Mossaheb N, Saria A, Schloegelhofer M, Zernig G (2007a) Pharmacokinetics and elimination of quetiapine, venlafaxine, and trazodone during pregnancy and postpartum. J Clin Psychopharmacol 27(6):720–722PubMedCrossRefGoogle Scholar
  50. Klier CM, Muzik M, Dervic K, Mossaheb N, Benesch T, Ulm B et al (2007b) The role of estrogen and progesterone in depression after birth. J Psychiatr Res 41(3–4):273–279PubMedCrossRefGoogle Scholar
  51. Klirova M, Novak T, Kopecek M, Mohr P, Strunzova V (2008) Repetitive transcranial magnetic stimulation (rTMS) in major depressive episode during pregnancy. Neuro Endocrinology Letters 29(1):69–70PubMedGoogle Scholar
  52. Marcus SM (2009) Depression during pregnancy: rates, risks and consequences—Motherisk update 2008. Can J Clin Pharmacol 16(1):e15–22PubMedGoogle Scholar
  53. McKenna K, Koren G, Tetelbaum M, Wilton L, Shakir S, Diav-Citrin O et al (2005) Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. The J of Clin Psychiatry 66(4):444–9, quiz 546CrossRefGoogle Scholar
  54. Milgrom J, Negri LM, Gemmill AW, McNeil M, Martin PR (2005) A randomized controlled trial of psychological interventions for postnatal depression. Br J Clin Psychol 44(Pt 4):529–542PubMedCrossRefGoogle Scholar
  55. Miller LJ (1994) Use of electroconvulsive therapy during pregnancy. Hospital & Community Psychiatry 45(5):444–450Google Scholar
  56. Misri S, Reebye P, Corral M, Milis L (2004) The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trial. J Clin Psychiatry 65(9):1236–1241PubMedCrossRefGoogle Scholar
  57. Moses-Kolko EL, Berga SL, Kalro B, Sit DK, Wisner KL (2009) Transdermal estradiol for postpartum depression: a promising treatment option. Clin Obstet Gynecol 52(3):516–529PubMedCrossRefGoogle Scholar
  58. Mulcahy R, Reay RE, Wilkinson RB, Owen C (2010) A randomised control trial for the effectiveness of group interpersonal psychotherapy for postnatal depression. Archives of Women’s Mental Health 13(2):125–139PubMedCrossRefGoogle Scholar
  59. Nahas Z, Marangell LB, Husain MM, Rush AJ, Sackeim HA, Lisanby SH et al (2005) Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry 66(9):1097–1104PubMedCrossRefGoogle Scholar
  60. Nonacs RM, Soares CN, Viguera AC, Pearson K, Poitras JR, Cohen LS (2005) Bupropion SR for the treatment of postpartum depression: a pilot study. Int J Neuropsychopharmacol 8(3):445–449PubMedCrossRefGoogle Scholar
  61. Oates M (2003) Perinatal psychiatric disorders: a leading cause of maternal morbidity and mortality. British Medical Bulletin 67:219–229PubMedCrossRefGoogle Scholar
  62. Oberlander TF, Warburton W, Misri S, Riggs W, Aghajanian J, Hertzman C (2008) Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data. Birth Defects Res B Dev Reprod Toxicol 83(1):68–76PubMedCrossRefGoogle Scholar
  63. Paulson JF, Bazemore SD (2010) Prenatal and postpartum depression in fathers and its association with maternal depression: a meta-analysis. JAMA 303(19):1961–1969PubMedCrossRefGoogle Scholar
  64. Pinette MG, Santarpio C, Wax JR, Blackstone J (2007) Electroconvulsive therapy in pregnancy. Obstet Gynecol 110(2 Pt 2):465–466PubMedCrossRefGoogle Scholar
  65. Rasmussen KG (2011) Some considerations in choosing electroconvulsive therapy versus transcranial magnetic stimulation for depression. J ECT 27(1):51–54PubMedCrossRefGoogle Scholar
  66. Reis M, Kallen B (2008) Maternal use of antipsychotics in early pregnancy and delivery outcome. J Clin Psychopharmacol 28(3):279–288PubMedCrossRefGoogle Scholar
  67. Rush AJ, George MS, Sackeim HA, Marangell LB, Husain MM, Giller C et al (2000) Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol Psychiatry 47(4):276–286PubMedCrossRefGoogle Scholar
  68. Sackeim HA, Rush AJ, George MS, Marangell LB, Husain MM, Nahas Z et al (2001) Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology 25(5):713–728PubMedCrossRefGoogle Scholar
  69. Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR (1998) Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 338(4):209–216PubMedCrossRefGoogle Scholar
  70. Sit DK, Perel JM, Helsel JC, Wisner KL (2008) Changes in antidepressant metabolism and dosing across pregnancy and early postpartum. J Clin Psychiatry 69(4):652–658PubMedCrossRefGoogle Scholar
  71. Smith S (1956) The use of electroplexy (E.C.T.) in psychiatric syndromes complicating pregnancy. J Ment Sci 102(429):796–800PubMedGoogle Scholar
  72. Sockol LE, Epperson CN, Barber JP (2011) A meta-analysis of treatments for perinatal depression. Clin Psychol Rev 31(5):839–849PubMedCrossRefGoogle Scholar
  73. Stowe ZN, Owens MJ, Landry JC, Kilts CD, Ely T, Llewellyn A et al (1997) Sertraline and desmethylsertraline in human breast milk and nursing infants. Am J Psychiatry 154(9):1255–1260PubMedGoogle Scholar
  74. Sugawara M, Toda MA, Shima S, Mukai T, Sakakura K, Kitamura T (1997) Premenstrual mood changes and maternal mental health in pregnancy and the postpartum period. J Clin Psychol 53(3):225–232PubMedCrossRefGoogle Scholar
  75. Suri R, Burt VK, Altshuler LL, Zuckerbrow-Miller J, Fairbanks L (2001) Fluvoxamine for postpartum depression. Am J Psychiatry 158(10):1739–1740PubMedCrossRefGoogle Scholar
  76. Suri R, Burt VK, Altshuler LL (2005) Nefazodone for the treatment of postpartum depression. Archives of Women’s Mental Health 8(1):55–56PubMedCrossRefGoogle Scholar
  77. US Food and Drug Administration (2008) VNS therapy system, premarket approval: supplement. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma_template.cfm?id=p970003s050. Accessed 28 June 2013
  78. Warden D, Rush AJ, Trivedi MH, Fava M, Wisniewski SR (2007) The STAR*D project results: a comprehensive review of findings. Current Psychiatry Reports 9(6):449–459PubMedCrossRefGoogle Scholar
  79. Wickramaratne P, Gameroff MJ, Pilowsky DJ, Hughes CW, Garber J, Malloy E et al (2011) Children of depressed mothers 1 year after remission of maternal depression: findings from the STAR*D-child study. Am J Psychiatry 168(6):593–602PubMedCrossRefGoogle Scholar
  80. Wiklund I, Mohlkert P, Edman G (2010) Evaluation of a brief cognitive intervention in patients with signs of postnatal depression: a randomized controlled trial. Acta Obstetricia Et Gynecologica Scandinavica 89(8):1100–1104PubMedCrossRefGoogle Scholar
  81. Wisner KL, Hanusa BH, Perel JM, Peindl KS, Piontek CM, Sit DK et al (2006) Postpartum depression: a randomized trial of sertraline versus nortriptyline. J Clin Psychopharmacol 26(4):353–360PubMedCrossRefGoogle Scholar
  82. Yonkers KA, Lin H, Howell HB, Heath AC, Cohen LS (2008) Pharmacologic treatment of postpartum women with new-onset major depressive disorder: a randomized controlled trial with paroxetine. J Clin Psychiatry 69(4):659–665PubMedCrossRefGoogle Scholar
  83. Yonkers KA, Gotman N, Smith MV, Forray A, Belanger K, Brunetto WL et al (2011) Does antidepressant use attenuate the risk of a major depressive episode in pregnancy? Epidemiology 22(6):848–854PubMedGoogle Scholar
  84. Zhang D, Hu Z (2009) RTMS may be a good choice for pregnant women with depression. Archives of Women’s Mental Health 12(3):189–190PubMedCrossRefGoogle Scholar
  85. Zhang X, Liu K, Sun J, Zheng Z (2010) Safety and feasibility of repetitive transcranial magnetic stimulation (rTMS) as a treatment for major depression during pregnancy. Archives of Women’s Mental Health 13(4):369–370PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 2013

Authors and Affiliations

  1. 1.Department of PsychiatryStanford University Medical CenterStanfordUSA

Personalised recommendations